Article info

Download PDFPDF
Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis
  1. Correspondence to Elad I Levy, University at Buffalo Neurosurgery, Millard Fillmore Gates Hospital, Kaleida Health, 3 Gates Circle, Buffalo, NY 14209, USA; elevy{at}ubns.com
View Full Text

Citation

Natarajan SK, Ogilvy CS, Hopkins LN, et al
Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis

Publication history

  • Received October 30, 2009
  • Revised December 15, 2009
  • Accepted December 18, 2009
  • First published May 27, 2010.
Online issue publication 
May 27, 2010

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.